Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors. - Burton EC; Lamborn KR; Forsyth P; Scott J; O'Campo J; Uyehara-Lock J; Prados M; Berger M; Passe S; Uhm J; O'Neill BP; Jenkins RB; et al. (Clinical cancer research : an official journal of the American Association for Cancer Research, 2002)